Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2

PLoS Neglected Tropical Diseases

Volumn 6, Issue 3, 2012, Pages

  Pearson, Mark S ^a   Pickering, Darren A ^a   McSorley, Henry J ^a   Bethony, Jeffrey M ^b   Tribolet, Leon ^a   Dougall, Annette M ^a   Hotez, Peter J ^c   Loukas, Alex ^a  

^a JAMES COOK UNIVERSITY   (Australia)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 4; NA APR 1 VACCINE; TETRASPANIN 2 VACCINE; UNCLASSIFIED DRUG; VACCINE; ALUMINUM POTASSIUM SULFATE; ALUMINUM SULFATE; ASPARTIC PROTEINASE; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; HELMINTH ANTIBODY; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYRIBONUCLEOTIDE; PARASITE ANTIGEN; RECOMBINANT VACCINE; TETRASPANIN;

ADULT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HOOKWORM; HUMAN; IMMUNIZATION; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MOUSE; NECATORIASIS; NONHUMAN; PARASITE LOAD; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; ADOLESCENT; AGED; ANIMAL; BLOOD; BRAZIL; C57BL MOUSE; CHILD; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INFANT; MIDDLE AGED; MONONUCLEAR CELL; PRESCHOOL CHILD; SECRETION; SPLEEN;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; ALUM COMPOUNDS; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; ASPARTIC ACID PROTEASES; BRAZIL; CHILD; CHILD, PRESCHOOL; CYTOKINES; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN G; INFANT; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES; RECOMBINANT FUSION PROTEINS; SCHISTOSOMIASIS; SPLEEN; TETRASPANINS; VACCINES, SYNTHETIC; YOUNG ADULT;

EID: 84859197342     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001564     Document Type: Article

References (32)

1. Hotez PJ, Bethony JM, Diemert DJ, Pearson M, Loukas A, (2010) Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nature reviews Microbiology 8: 814-826.
2. King CH, Dangerfield-Cha M, (2008) The unacknowledged impact of chronic schistosomiasis. Chronic illness 4: 65-79.
3. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, et al. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86: 125-139.
4. King CH, Sturrock RF, Kariuki HC, Hamburger J, (2006) Transmission control for schistosomiasis- why it matters now. Trends in parasitology 22: 575-582.
5. Bergquist R, Utzinger J, McManus DP, (2008) Trick or treat: the role of vaccines in integrated schistosomiasis control. PLoS neglected tropical diseases 2: e244.
6. McManus DP, Loukas A, (2008) Current status of vaccines for schistosomiasis. Clinical microbiology reviews 21: 225-242.
7. Clements AC, Bosque-Oliva E, Sacko M, Landoure A, Dembele R, et al. (2009) A comparative study of the spatial distribution of schistosomiasis in Mali in 1984-1989 and 2004-2006. PLoS neglected tropical diseases 3: e431.
8. Bergquist NR, Leonardo LR, Mitchell GF, (2005) Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends in parasitology 21: 112-117.
9. Gray DJ, McManus DP, Li Y, Williams GM, Bergquist R, et al. (2010) Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect Dis 10: 733-736.
10. Braschi S, Wilson RA, (2006) Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics 5: 347-356.
11. Loukas A, Tran M, Pearson MS, (2007) Schistosome membrane proteins as vaccines. International journal for parasitology 37: 257-263.
12. Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, et al. (2006) Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nature medicine 12: 835-840.
13. Da'dara AA, Li YS, Xiong T, Zhou J, Williams GM, et al. (2008) DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 26: 3617-3625.
14. Da'dara AA, Skelly PJ, Wang MM, Harn DA, (2001) Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine 20: 359-369.
15. Yuan C, Fu YJ, Li J, Yue YF, Cai LL, et al. (2010) Schistosoma japonicum: efficient and rapid purification of the tetraspanin extracellular loop 2, a potential protective antigen against schistosomiasis in mammalian. Exp Parasitol 126: 456-461.
16. Tran MH, Freitas TC, Cooper L, Gaze S, Gatton ML, et al. (2010) Suppression of mRNAs encoding tegument tetraspanins from Schistosoma mansoni results in impaired tegument turnover. PLoS pathogens 6: e1000840.
17. Pearson MS, Pickering DA, Tribolet L, Cooper L, Mulvenna J, et al. (2010) Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis. The Journal of infectious diseases 201: 1561-1569.
18. Hotez PJ, Bethony JM, Oliveira SC, Brindley PJ, Loukas A, (2008) Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis. Expert Rev Vaccines 7: 745-752.
19. Diemert DJ, Pinto AG, Freire J, Jariwala A, Hamilton R, Periago MV, Loukas A, Tribolet L, Mulvenna J, Correa-Oliveira R, Hotez PJ, Bethony JM, (2011) Generalized Urticaria Induced by the Na-ASP-2 Hookworm Vaccine- Implications for the Development of Vaccines against Helminths. J Allerg Clin Immunol.
20. Studier FW, (2005) Protein production by auto-induction in high density shaking cultures. Protein Expr Purif 41: 207-234.
21. Harn DA, Mitsuyama M, David JR, (1984) Schistosoma mansoni. Anti-egg monoclonal antibodies protect against cercarial challenge in vivo. J Exp Med 159: 1371-1387.
22. Hotez P, (2011) A handful of 'antipoverty' vaccines exist for neglected diseases, but the world's poorest billion people need more. Health Aff (Millwood) 30: 1080-1087.
23. Pearson MS, Bethony JM, Pickering DA, de Oliveira LM, Jariwala A, et al. (2009) An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection. FASEB J 23: 3007-3019.
24. Fitzsimmons CM, McBeath R, Joseph S, Jones FM, Walter K, et al. (2007) Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: Molecular structure and patterns of in vivo exposure. Int Arch Allergy Immunol 142: 40-50.
25. Brindley PJ, Kalinna BH, Wong JY, Bogitsh BJ, King LT, et al. (2001) Proteolysis of human hemoglobin by schistosome cathepsin D. Mol Biochem Parasitol 112: 103-112.
26. Hewitson JP, Hamblin PA, Mountford AP, (2005) Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol 27: 271-280.
27. Wynn TA, Oswald IP, Eltoum IA, Caspar P, Lowenstein CJ, et al. (1994) Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J Immunol 153: 5200-5209.
28. Cardoso FC, Macedo GC, Gava E, Kitten GT, Mati VL, et al. (2008) Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS neglected tropical diseases 2: e308.
29. Garcia TC, Fonseca CT, Pacifico LG, Duraes Fdo V, Marinho FA, et al. (2008) Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice. Acta Trop 106: 162-167.
30. Bergquist NR, Colley DG, (1998) Schistosomiasis vaccine:research to development. Parasitol Today 14: 99-104.
31. Castro-Borges W, Simpson DM, Dowle A, Curwen RS, Thomas-Oates J, et al. (2011) Abundance of tegument surface proteins in the human blood fluke Schistosoma mansoni determined by QconCAT proteomics. J Proteomics 74: 1519-1533.
32. Cupit PM, Steinauer ML, Tonnessen BW, Eric Agola L, Kinuthia JM, et al. (2011) Polymorphism associated with the Schistosoma mansoni tetraspanin-2 gene. International journal for parasitology 41: 1249-1252.